Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients

Alexandra Tauzin; Guillaume Beaudoin-Bussieres; Shang Yu Gong; Debashree Chatterjee; Gabrielle Gendron-Lepage; Catherine Bourassa; Guillaume Goyette; Normand Racine; Zineb Khrifi; Julie Turgeon; Cecile Tremblay; Valerie Martel-Laferriere; Daniel E Kaufmann; Marc Cloutier; Renee Bazin; Ralf E. Duerr; Melanie Dieude; Marie-Josee Hebert; Andres Finzi.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-22275056

Documentos relacionados

  1. Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients.
  2. Reduced neutralization and Fc effector function to Omicron subvariants in sera from SARS-CoV-1 survivors after two doses of CoronaVac plus one dose subunit vaccine.
  3. Circular RNA vaccines against SARS-CoV-2 and emerging variants.
  4. Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice.
  5. Comparison of BNT162b2 and mRNA1273 vaccines in solid organ transplant recipients: Post-Hoc analysis of a Japanese national prospective study.
  6. Advances in the Omicron variant development.
  7. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency.
  8. Rapid Selection of Sotrovimab Escape Variants in Severe Acute Respiratory Syndrome Coronavirus 2 Omicron-Infected Immunocompromised Patients.
  9. Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults.
  10. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants.